Cargando…

Boceprevir: A new hope against hepatitis C virus

Detalles Bibliográficos
Autores principales:	Brashier, Dick B. S., Sharma, Sushil, Mathur, A. G., Khare, Pragya, Gupta, Sparsh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Molecules of the Millennium
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356973/ https://www.ncbi.nlm.nih.gov/pubmed/22629107 http://dx.doi.org/10.4103/0976-500X.95548

Ejemplares similares

Naloxegol: First oral peripherally acting mu opioid receptor antagonists for opioid-induced constipation
por: Anantharamu, Tejus, et al.
Publicado: (2015)

Fingolimod (FTY720): First approved oral therapy for multiple sclerosis
por: Sharma, Sushil, et al.
Publicado: (2011)

Macitentan: An important addition to the treatment of pulmonary arterial hypertension
por: Khadka, Anjan, et al.
Publicado: (2015)

Lorcaserin: A novel antiobesity drug
por: Brashier, Dick B. S., et al.
Publicado: (2014)

Sofosbuvir: A novel treatment option for chronic hepatitis C infection
por: Bhatia, Harmeet Kaur, et al.
Publicado: (2014)

Asenapine, a new sublingual atypical antipsychotic
por: Balaraman, R, et al.
Publicado: (2010)

An upcoming drug for onychomycosis: Tavaborole
por: Sharma, Neha, et al.
Publicado: (2015)

Delamanid: A new armor in combating drug-resistant tuberculosis
por: Xavier, Alphienes Stanley, et al.
Publicado: (2014)

Belimumab: First targeted biological treatment for systemic lupus erythematosus
por: Dubey, Ashok K., et al.
Publicado: (2011)

Ticagrelor: An emerging oral antiplatelet agent
por: Juneja, Shivani, et al.
Publicado: (2013)

Proprotein convertase subtilisin/kexin type 9 enzyme inhibitors: An emerging new therapeutic option for the treatment of dyslipidemia
por: Mazhar, Faizan, et al.
Publicado: (2016)

Ceftaroline fosamil: A novel anti-Methicillin-resistant Staphylococcus aureus cephalosporin
por: Girish, C., et al.
Publicado: (2011)

Telavancin: A novel lipoglycopeptide antibiotic
por: Damodaran, S. E., et al.
Publicado: (2011)

Belatacept: A worthy alternative to cyclosporine?
por: Melvin, George, et al.
Publicado: (2012)

Agomelatine: A novel melatonergic antidepressant
por: Manikandan, S
Publicado: (2010)

Bedaquiline: A novel drug to combat multiple drug-resistant tuberculosis
por: Goel, Divya
Publicado: (2014)

Fospropofol
por: Mahajan, Bharti, et al.
Publicado: (2012)

Istaroxime: A rising star in acute heart failure
por: Aditya, Suruchi, et al.
Publicado: (2012)

Suvorexant: The first orexin receptor antagonist to treat insomnia
por: Dubey, Ashok K., et al.
Publicado: (2015)

Lifitegrast: A novel drug for treatment of dry eye disease
por: Abidi, Afroz, et al.
Publicado: (2016)

New developments in the management of hepatitis C virus infection: focus on boceprevir
por: Berenguer, Marina, et al.
Publicado: (2012)

Boceprevir and personalized medicine in hepatitis C virus infection
por: Habersetzer, François, et al.
Publicado: (2012)

The Millennium Project: the positive health implications of improved environmental sustainability
por: Melnick, Don J, et al.
Publicado: (2005)

Disease Emergence and Health Transitions in the Last Millennium
por: Donaldson, Liam
Publicado: (2000)

Will Medicine Be Revolutionised by Genomics?
por: Harris, Rodney
Publicado: (2000)

God, Mammon and the Physician: Medicine in England before the College
por: Rawcliffe, Carole
Publicado: (2000)

Changing Concepts of Health and Disease during the 20th Century
por: Booth, Christopher C
Publicado: (2000)

Imaging in Medicine through the 20th Century
por: Du Boulay, George
Publicado: (2000)

Foot-and-mouth disease virus 3C protease: Recent structural and functional insights into an antiviral target
por: Curry, Stephen, et al.
Publicado: (2007)

Hepatitis C in Brazil: lessons learned with boceprevir and telaprevir
por: Gomes, Lenyta Oliveira, et al.
Publicado: (2018)

Boceprevir
Publicado: (2012)

Formulary Management of the Protease Inhibitors Boceprevir and Telaprevir for Chronic Hepatitis C Virus
por: Tungol, Alexandra, et al.
Publicado: (2011)

Molecules for the millennium: how will they look? New drug discovery year 2000
por: Sausville, E A, et al.
Publicado: (2000)

Protein tyrosine phosphatase receptor type C (PTPRC or CD45)
por: Al Barashdi, Maryam Ahmed, et al.
Publicado: (2021)

Telaprevir or boceprevir for hepatitis C treatment: a first survey on pharmacoutilization
por: Capuozzo, Maurizio, et al.
Publicado: (2013)

Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection
por: Bichoupan, Kian, et al.
Publicado: (2017)

Boceprevir-Based Triple Antiviral Therapy for Chronic Hepatitis C Virus Infection in Kidney-Transplant Candidates
por: Mehawej, Mireille, et al.
Publicado: (2015)

Economic Evaluation of Boceprevir for the Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus Infection in Hungary
por: Odhiambo, Raymond, et al.
Publicado: (2013)

JP Howard Fee MD, PhD, FFARCSI Introduction of The WFK Morrow Lecture
Publicado: (1998)

AA Jennifer Adgey MD, FRCP, FRCPI, FACC Introducion of the Calvert Lecture
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_9soqcfbetdlg70mhe6qant88k2